ELGX - Endologix, Inc.
| Previous close | 2.2200 |
| Open | 2.2000 |
| Bid | 2.1200 x 1000 |
| Ask | 2.7000 x 1300 |
| Day's range | 2.1350 - 2.2500 |
| 52-week range | 2.1350 - 8.9000 |
| Volume | 126,594 |
| Avg. volume | 163,606 |
| Market cap | 39M |
| Beta (3Y monthly) | 0.30 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Endologix (ELGX) Reports Q3 Loss, Tops Revenue Estimates
Endologix (ELGX) delivered earnings and revenue surprises of 15.63% and 1.46%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Endologix (ELGX) Expected to Beat Earnings Estimates: Should You Buy?
Endologix (ELGX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
Should You Take Comfort From Insider Transactions At Endologix, Inc. (NASDAQ:ELGX)?
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...
- Simply Wall St.
Health Check: How Prudently Does Endologix (NASDAQ:ELGX) Use Debt?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
- Zacks
Endologix (ELGX) Reports Q2 Loss, Tops Revenue Estimates
Endologix (ELGX) delivered earnings and revenue surprises of 53.75% and 0.41%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Will Endologix (ELGX) Report Negative Earnings Next Week? What You Should Know
Endologix (ELGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Endologix, Inc. (ELGX) Shares March Higher, Can It Continue?
As of late, it has definitely been a great time to be an investor in Endologix, Inc. (ELGX).
- Simply Wall St.
Investors Who Bought Endologix (NASDAQ:ELGX) Shares Five Years Ago Are Now Down 95%
Endologix, Inc. (NASDAQ:ELGX) shareholders should be happy to see the share price up 15% in the last month. But that...
- Zacks
Zacks.com featured highlights include: Avis, California Resources, Brinker, Endologix and Brookdale
Zacks.com featured highlights include: Avis, California Resources, Brinker, Endologix and Brookdale
- Zacks
5 Broker-Friendly Stocks to Combat Market Jitters
In view of the ongoing uncertainties it is in the best interest of investors to seek guidance from brokers for designing a winning portfolio of stocks.
- Zacks
Endologix (ELGX) Reports Q1 Loss, Tops Revenue Estimates
Endologix (ELGX) delivered earnings and revenue surprises of 28.21% and 4.19%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Endologix (ELGX) Upgraded to Strong Buy: Here's Why
Endologix (ELGX) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Simply Wall St.
What Should We Expect From Endologix, Inc.’s (NASDAQ:ELGX) Earnings Over The Next Few Years?
Endologix, Inc.'s (NASDAQ:ELGX) released its most recent earnings update in December 2018, which suggested company earnings became less negative compared to the previous year's level - great news for investorsRead More...
- Zacks
All You Need to Know About Endologix (ELGX) Rating Upgrade to Buy
Endologix (ELGX) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Zacks
Endologix (ELGX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Endologix (ELGX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
WellCare Health (WCG) Q4 Earnings Beat Estimates, Soar Y/Y
WellCare Health's (WCG) Q4 earnings gain from Meridian buyout and growth in membership.
- Zacks
Humana's (HUM) Q4 Earnings Surpass Estimates, Improve Y/Y
Humana's (HUM) fourth-quarter earnings gain on the back of Medicare Advantage membership growth and operating efficiencies.
- Zacks
Centene's (CNC) Earnings Top Estimates in Q4, Surge Y/Y
Centene's (CNC) Q4 earnings ride high on robust revenues, solid acquisitions and stronger Health Insurance Marketplace business.
- Simply Wall St.
What Kind Of Shareholder Owns Most Endologix, Inc. (NASDAQ:ELGX) Stock?
The big shareholder groups in Endologix, Inc. (NASDAQ:ELGX) have power over the company. Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. Read More...
